EFO:ARCA-ProShares Ultra MSCI EAFE (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 41.797

Change

-0.19 (-0.45)%

Market Cap

USD 0.01B

Volume

178.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the MSCI EAFE Index?. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index includes 85% of free float-adjusted, market capitalization in each industry group in developed market countries, excluding the U.S. and Canada. The fund is non-diversified.

Inception Date: 04/06/2009

Primary Benchmark: MSCI EAFE GR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.25%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.82B

ETFs Containing EFO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.27% 30% F 31% F
Dividend Return 1.49% 66% D+ 24% F
Total Return -0.79% 30% F 25% F
Trailing 12 Months  
Capital Gain -2.27% 30% F 31% F
Dividend Return 1.49% 66% D+ 24% F
Total Return -0.79% 30% F 25% F
Trailing 5 Years  
Capital Gain -2.62% 48% F 46% F
Dividend Return 3.41% 58% F 8% B-
Total Return 0.79% 47% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain 10.86% 27% F 67% D+
Dividend Return 11.53% 27% F 63% D
Total Return 0.67% 59% D- 18% F
Risk Return Profile  
Volatility (Standard Deviation) 38.51% 90% A- 26% F
Risk Adjusted Return 29.93% 54% F 44% F
Market Capitalization 0.01B 6% D- 5% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.